ロード中...
Treatment with JAK inhibitors in myelofibrosis patients nullifies the prognostic impact of unfavorable cytogenetics
MICRO ABSTRACT: In the era before the advent of JAK inhibitors, cytogenetic information was used to predict survival in myelofibrosis patients. However, the prognostic value of cytogenetics in the setting of JAK inhibitor therapy remains unknown. Our analyses suggest that initiation of JAK inhibitor...
保存先:
| 出版年: | Clin Lymphoma Myeloma Leuk |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5927833/ https://ncbi.nlm.nih.gov/pubmed/29574002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2018.02.019 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|